PAPER Alvarado CX, Makarious MB, Weller CA, Vitale D, Koretsky MJ, Bandres-Ciga S, Iwaki H, Levine K, Singleton A, Faghri F, Nalls MA, Leonard HL
SEARCH RESULTS
331007 RESULTS
PAPER Sabatini S, Martyr A, Hunt A, Gamble LD, Matthews FE, Thom JM, Jones RW, Allan L, Knapp M, Victor C, Pentecost C, Rusted JM, Morris RG, Clare L
Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme.
BMC Geriatr. 2024 Jan 5;24(1):23. PubMed: 38182985PAPER Portugal CC
Ascorbate and its transporter SVCT2: The dynamic duo's integrated roles in CNS neurobiology and pathophysiology.
Free Radic Biol Med. 2024 Feb 20;212:448-462. Epub 2024 Jan 3 PubMed: 38182073PAPER Ayaz M, Mosa OF, Nawaz A, Hamdoon AA, Elkhalifa ME, Sadiq A, Ullah F, Ahmed A, Kabra A, Khan H, Murthy HC
Neuroprotective potentials of Lead phytochemicals against Alzheimer's disease with focus on oxidative stress-mediated signaling pathways: Pharmacokinetic challenges, target specificity, clinical trials and future perspectives.
Phytomedicine. 2024 Feb;124:155272. Epub 2023 Dec 12 PubMed: 38181530PAPER Cilia ND, De Stefano C, Fontanella F, Siniscalchi SM
How word semantics and phonology affect handwriting of Alzheimer's patients: A machine learning based analysis.
Comput Biol Med. 2024 Feb;169:107891. Epub 2023 Dec 22 PubMed: 38181607PAPER Lee YJ, Rio DC
A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks.
Genes Dev. 2024 Feb 13;38(1-2):11-30. PubMed: 38182429PAPER Ruiz-Gabarre D, Vallés-Saiz L, Carnero-Espejo A, Ferrer I, Hernández F, Garcia-Escudero R, Ávila J, García-Escudero V
Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3.
EBioMedicine. 2024 Feb;100:104953. Epub 2024 Jan 5 PubMed: 38181704PAPER Kommaddi RP, Gowaikar R, P A H, Diwakar L, Singh K, Mondal A
Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer's disease mouse model.
J Biol Chem. 2024 Feb;300(2):105619. Epub 2024 Jan 3 PubMed: 38182004Shinya Yokomizo
Massachusetts General HospitalBoston, United States
Brenda Mcintosh
Black Creek
Vu Dang
PAPER Tayama T, Okada H, Ogawa K, Marsteller D, Maeda H, Hruska MW, Kagawa Y
Population Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW-6356 and Its Active Metabolite Following Single and Multiple Oral Administration in Healthy Individuals and Patients with Parkinson's Disease.
Clin Pharmacol Drug Dev. 2024 Jan 4; PubMed: 38178727PAPER Chaplygina AV, Kovalev VI, Zhdanova DY
[The study of lipofuscin levels in the 5xFAD mouse model of Alzheimer's disease.].
Adv Gerontol. 2023;36(5):720-728. PubMed: 38180372PAPER Bocti C
Health system change for new therapies in Alzheimer's Disease: putting the cart before the horse?
Can J Neurol Sci. 2024 Jan 5;:1-6. PubMed: 38178734PAPER Li X, Chen X, Gao X
Copper and cuproptosis: new therapeutic approaches for Alzheimer's disease.
Front Aging Neurosci. 2023;15:1300405. Epub 2023 Dec 19 PubMed: 38178962Current Filters
No filters selected